Theravance Biopharma, Inc. (TBPH) SEC Filings — 2025
16 SEC filings for Theravance Biopharma, Inc. (TBPH) in 2025.
Filings
- Theravance Biopharma Files 8-K Report — 8-K · Dec 8, 2025
- Theravance Biopharma Swings to Profit on Milestone Gain, YUPELRI China Approval — 10-Q · Nov 12, 2025
- Theravance Biopharma Files 8-K on Financials — 8-K · Nov 10, 2025
- Theravance Biopharma Files 8-K: Other Events & Exhibits — 8-K · Aug 25, 2025
- Theravance Biopharma Files 8-K: Other Event Reported — 8-K · Aug 20, 2025
- Theravance Biopharma Swings to Profit on $75M Royalty Gain, China Approval — 10-Q · Aug 13, 2025
- Theravance Biopharma Files 8-K on Operations — 8-K · Aug 12, 2025
- Theravance Biopharma Files 8-K Report — 8-K · Jun 26, 2025
- Theravance Biopharma Files 8-K for Other Events — 8-K · Jun 6, 2025
- Royalty Pharma Acquires Theravance Biopharma — 8-K · Jun 2, 2025
- Theravance Biopharma Files 8-K on Shareholder Vote Matters — 8-K · May 20, 2025
- Theravance Biopharma Files Q1 2025 10-Q — 10-Q · May 12, 2025
- Theravance Biopharma Files 8-K on Financials — 8-K · May 8, 2025
- Theravance Biopharma Files Definitive Proxy Statement — DEF 14A · Apr 10, 2025
- Theravance Biopharma Files 2024 10-K — 10-K · Mar 7, 2025
- Theravance Biopharma Files 8-K on Financials — 8-K · Feb 26, 2025